Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Serina Therapeutics, Inc.AGE · Entity 9581 | Chief Executive Officer | March 11, 2023 | March 15, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Serina Therapeutics, Inc.
Report date March 11, 2023 · Filed March 15, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.0001 par valueSEC Table I · non-derivative | Direct | 41,982 |
Last balance in matching sequence
After 2023-03-11 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-03-11 · Exercise / conversion · Acquired 3,125 · Balance 43,042 F1: Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership. Row 2 · 2023-03-11 · Tax withholding · Disposed 1,060 · Balance 41,982 F2: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. F1: Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2023-03-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-11 · Exercise / conversion · Disposed 3,125 · Balance 0 F3: Restricted Stock Units vested on March 11, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership.
F2: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
F3: Restricted Stock Units vested on March 11, 2023.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Lineage Cell Therapeutics, Inc.
Report date September 17, 2018 · Filed September 20, 2018
Section 16 reporting ended · disclosed 2018-09-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, no par valueSEC Table I · non-derivative | Direct | 893,913 |
Last balance in matching sequence
After 2018-09-17 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2018-09-17 · Exercise / conversion · Acquired 10,938 · Balance 897,696 F1: Does not include shares that may be acquired upon the exercise of certain stock options. Row 2 · 2018-09-17 · Tax withholding · Disposed 3,783 · Balance 893,913 F2: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 10,938 Restricted Stock Units, the grant of which was previously reported on a Form 4. F1: Does not include shares that may be acquired upon the exercise of certain stock options. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-09-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-09-17 · Exercise / conversion · Disposed 10,938 · Balance 0 F3: Restricted Stock Units vested on September 17, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: Does not include shares that may be acquired upon the exercise of certain stock options.
F2: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 10,938 Restricted Stock Units, the grant of which was previously reported on a Form 4.
F3: Restricted Stock Units vested on September 17, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2023 Filed Mar 15, 2023 01:32 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018774 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Restricted Stock Units vested on March 11, 2023. F3 · derivative.expiration_date: Restricted Stock Units vested on March 11, 2023. Read SEC document |
| March 11, 2023 Filed Mar 15, 2023 01:32 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,060 | $0.59 | $625.40 |
DisclosureSEC source: 0001209191-23-018774 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,982 F2 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. F1 · balance_after: Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership. Read SEC document |
| March 11, 2023 Filed Mar 15, 2023 01:32 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018774 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership. Read SEC document |
| December 11, 2022 Filed Dec 14, 2022 02:22 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061094 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Restricted Stock Units vested on December 11, 2022. F3 · derivative.expiration_date: Restricted Stock Units vested on December 11, 2022. Read SEC document |
| December 11, 2022 Filed Dec 14, 2022 02:22 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,081 | $0.59 | $637.79 |
DisclosureSEC source: 0001209191-22-061094 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,917 F2 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. F1 · balance_after: Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership. Read SEC document |
| December 11, 2022 Filed Dec 14, 2022 02:22 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061094 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership. Read SEC document |
| September 11, 2022 Filed Sep 13, 2022 23:53 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-049787 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted Stock Units vested on September 11, 2022. F2 · derivative.expiration_date: Restricted Stock Units vested on September 11, 2022. Read SEC document |
| September 11, 2022 Filed Sep 13, 2022 23:53 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,081 | $0.56 | $607.85 |
DisclosureSEC source: 0001209191-22-049787 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,503 F1 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Read SEC document |
| September 11, 2022 Filed Sep 13, 2022 23:53 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-049787 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2022 Filed Jun 14, 2022 23:14 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036809 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted Stock Units vested on June 11, 2022. F2 · derivative.expiration_date: Restricted Stock Units vested on June 11, 2022. Read SEC document |
| June 11, 2022 Filed Jun 14, 2022 23:14 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,081 | $0.77 | $832.59 |
DisclosureSEC source: 0001209191-22-036809 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,459 F1 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Read SEC document |
| June 11, 2022 Filed Jun 14, 2022 23:14 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036809 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 00:14 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019000 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted Stock Units vested on March 11, 2022. F2 · derivative.expiration_date: Restricted Stock Units vested on March 11, 2022. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 00:14 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,281 | $0.69 | $886.84 |
DisclosureSEC source: 0001209191-22-019000 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,415 F1 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 00:14 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019000 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2021 Filed Dec 15, 2021 00:17 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-069617 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted Stock Units vested on December 11, 2021. F2 · derivative.expiration_date: Restricted Stock Units vested on December 11, 2021. Read SEC document |
| December 11, 2021 Filed Dec 15, 2021 00:17 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,081 | $0.64 | $686.44 |
DisclosureSEC source: 0001209191-21-069617 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,571 F1 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Read SEC document |
| December 11, 2021 Filed Dec 15, 2021 00:17 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-069617 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2021 Filed Sep 22, 2021 01:14 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-057189 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted Stock Units vested on September 11, 2021. F2 · derivative.expiration_date: Restricted Stock Units vested on September 11, 2021. Read SEC document |
| September 11, 2021 Filed Sep 22, 2021 01:14 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,081 | $1.00 | $1,078.30 |
DisclosureSEC source: 0001209191-21-057189 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,527 F1 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Read SEC document |
| September 11, 2021 Filed Sep 22, 2021 01:14 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-057189 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2021 Filed Jun 16, 2021 01:12 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040796 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,875 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted Stock Units vested on June 11, 2021. F2 · derivative.expiration_date: Restricted Stock Units vested on June 11, 2021. Read SEC document |
| June 11, 2021 Filed Jun 16, 2021 01:12 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,081 | $1.53 | $1,653.93 |
DisclosureSEC source: 0001209191-21-040796 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,483 F1 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Read SEC document |
| June 11, 2021 Filed Jun 16, 2021 01:12 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040796 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 23:20 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | GrantOption to Purchase Common Stock · Derivative | 120,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001209191-21-039033 · doc4.xml · derivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date. Read SEC document |
| March 11, 2021 Filed Mar 16, 2021 01:35 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020633 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted Stock Units vested on March 11, 2021. F2 · derivative.expiration_date: Restricted Stock Units vested on March 11, 2021. Read SEC document |
| March 11, 2021 Filed Mar 16, 2021 01:35 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,284 | $2.03 | $2,606.52 |
DisclosureSEC source: 0001209191-21-020633 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,439 F1 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Read SEC document |
| March 11, 2021 Filed Mar 16, 2021 01:35 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020633 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2020 Filed Dec 16, 2020 02:33 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-063668 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,125 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted Stock Units vested on December 11, 2020. F2 · derivative.expiration_date: Restricted Stock Units vested on December 11, 2020. Read SEC document |
| December 11, 2020 Filed Dec 16, 2020 02:33 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,081 | $1.69 | $1,826.89 |
DisclosureSEC source: 0001209191-20-063668 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,598 F1 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Read SEC document |
| December 11, 2020 Filed Dec 16, 2020 02:33 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-063668 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2020 Filed Sep 16, 2020 01:37 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-050615 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted Stock Units vested on September 11, 2020. F2 · derivative.expiration_date: Restricted Stock Units vested on September 11, 2020. Read SEC document |
| September 11, 2020 Filed Sep 16, 2020 01:37 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,081 | $0.81 | $875.07 |
DisclosureSEC source: 0001209191-20-050615 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,554 F1 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Read SEC document |
| September 11, 2020 Filed Sep 16, 2020 01:37 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-050615 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2020 Filed Jun 16, 2020 01:29 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-036856 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,375 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted Stock Units vested on June 11, 2020. F2 · derivative.expiration_date: Restricted Stock Units vested on June 11, 2020. Read SEC document |
| June 11, 2020 Filed Jun 16, 2020 01:29 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 1,081 | $0.80 | $864.91 |
DisclosureSEC source: 0001209191-20-036856 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,510 F1 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Read SEC document |
| June 11, 2020 Filed Jun 16, 2020 01:29 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-036856 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2020 Filed Mar 14, 2020 01:43 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionRestricted Stock Units · Derivative | 12,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019073 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted Stock Units vested on March 11, 2020. F2 · derivative.expiration_date: Restricted Stock Units vested on March 11, 2020. Read SEC document |
| March 11, 2020 Filed Mar 14, 2020 01:43 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Tax withholdingCommon Stock, $0.0001 par value | 5,085 | $0.88 | $4,463.10 |
DisclosureSEC source: 0001209191-20-019073 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,446 F1 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 12,500 Restricted Stock Units, the grant of which was previously reported on a Form 4. Read SEC document |
| March 11, 2020 Filed Mar 14, 2020 01:43 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | Exercise / conversionCommon Stock, $0.0001 par value | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019073 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2019 Filed Mar 14, 2019 01:52 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | GrantRestricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019321 · doc4.xml · derivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F2 · derivative.exercise_price: Grant of restricted stock units under the AgeX 2017 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: One quarter of the restricted stock units shall vest upon the completion of 12 months of continuous employment from the date of grant and the balance shall vest in twelve equal quarterly installments upon completion of each quarter of continuous service. F3 · derivative.expiration_date: One quarter of the restricted stock units shall vest upon the completion of 12 months of continuous employment from the date of grant and the balance shall vest in twelve equal quarterly installments upon completion of each quarter of continuous service. Read SEC document |
| March 11, 2019 Filed Mar 14, 2019 01:52 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | GrantOption to Purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-19-019321 · doc4.xml · derivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-03-10 F1 · derivative.exercise_date: One quarter shall vest on March 11, 2020 and the remaining shall vest monthly over 36 months, based upon continuous service. Read SEC document |
| December 10, 2018 Filed Dec 13, 2018 01:30 UTC | Serina Therapeutics, Inc. AGE · Entity 9581 | PurchaseCommon Stock, $0.0001 par value | 4,000 | $3.86 | $15,442.80 |
DisclosureSEC source: 0001209191-18-062349 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,460 F1 · price: The price of $3.8607 per share represents a weighted average of prices ranging from $3.8566 to $3.8634 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| September 17, 2018 Filed Sep 20, 2018 01:38 UTC | Lineage Cell Therapeutics, Inc. BTX · Entity 6045 | Exercise / conversionRestricted Stock Units · Derivative | 10,938 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-051725 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 10,938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Restricted Stock Units vested on September 17, 2018. F3 · derivative.expiration_date: Restricted Stock Units vested on September 17, 2018. Read SEC document |
| September 17, 2018 Filed Sep 20, 2018 01:38 UTC | Lineage Cell Therapeutics, Inc. BTX · Entity 6045 | Tax withholdingCommon Shares, no par value | 3,783 | $2.31 | $8,738.73 |
DisclosureSEC source: 0001209191-18-051725 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 893,913 F2 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 10,938 Restricted Stock Units, the grant of which was previously reported on a Form 4. F1 · balance_after: Does not include shares that may be acquired upon the exercise of certain stock options. Read SEC document |
| September 17, 2018 Filed Sep 20, 2018 01:38 UTC | Lineage Cell Therapeutics, Inc. BTX · Entity 6045 | Exercise / conversionCommon Shares, no par value | 10,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-051725 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 897,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Does not include shares that may be acquired upon the exercise of certain stock options. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 23:50 UTC | Lineage Cell Therapeutics, Inc. BTX · Entity 6045 | Exercise / conversionRestricted Stock Units · Derivative | 1,562 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042495 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,938 Underlying: Common Shares · 1,562 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Restricted Stock Units vested on July 10, 2018. F3 · derivative.expiration_date: Restricted Stock Units vested on July 10, 2018. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 23:50 UTC | Lineage Cell Therapeutics, Inc. BTX · Entity 6045 | Tax withholdingCommon Shares, no par value | 541 | $2.20 | $1,190.20 |
DisclosureSEC source: 0001209191-18-042495 · doc4.xml · nonDerivative · entry 2 WEST MICHAEL D · CIK 0001202529 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 886,758 F2 · kind: Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,562 Restricted Stock Units, the grant of which was previously reported on a Form 4. F1 · balance_after: Does not include 10,938 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 23:50 UTC | Lineage Cell Therapeutics, Inc. BTX · Entity 6045 | Exercise / conversionCommon Shares, no par value | 1,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042495 · doc4.xml · nonDerivative · entry 1 WEST MICHAEL D · CIK 0001202529 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 887,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Does not include 10,938 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options. Read SEC document |
| April 10, 2018 Filed Apr 13, 2018 01:00 UTC | Lineage Cell Therapeutics, Inc. BTX · Entity 6045 | Exercise / conversionRestricted Stock Units · Derivative | 1,563 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-024791 · doc4.xml · derivative · entry 3 WEST MICHAEL D · CIK 0001202529 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Shares · 1,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Restricted Stock Units vested on April 10, 2018. F3 · derivative.expiration_date: Restricted Stock Units vested on April 10, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.